Yingli Qiao
Taizhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparison of Three Gallbladder Drainage Methods for Acute Cholecystitis: A Systematic Review With Network Meta-Analysis.
Journal: ANZ journal of surgery
Published: November 22, 2024
The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review.
Journal: BMC cancer
Published: July 27, 2024
A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection.
Journal: Frontiers in pharmacology
Published: June 04, 2024
Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review.
Journal: Frontiers in oncology
Published: January 21, 2024
Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
Journal: World journal of surgical oncology
Published: November 04, 2023
Effect of intermittent Pringle maneuver on perioperative outcomes and long-term survival following liver resection in patients with hepatocellular carcinoma: a meta-analysis and systemic review.
Journal: World journal of surgical oncology
Published: September 16, 2023
Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies.
Journal: Frontiers in oncology
Published: May 29, 2023
Hepatocyte-derived extracellular vesicles miR-122-5p promotes hepatic ischemia reperfusion injury by regulating Kupffer cell polarization.
Journal: International immunopharmacology
Published: December 15, 2022
Hepatocellular HO-1 mediated iNOS-induced hepatoprotection against liver ischemia reperfusion injury.
Journal: Biochemical and biophysical research communications
Published: November 07, 2019
Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1.
Journal: Biochemical and biophysical research communications
Published: April 11, 2019
Hepatocellular iNOS protects liver from ischemia/reperfusion injury through HSF1-dependent activation of HSP70.
Journal: Biochemical and biophysical research communications
Published: March 13, 2019
Last Updated: 09/26/2026